MEDICAMEQ — Medicamen Biotech Share News
0.000.00%
Last trade - 00:00- IN₹3.11bn
- IN₹3.28bn
- IN₹1.98bn
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma
Brief: Medicamen Biotech Signs Distribution Agreement With XGX Pharma For European Market
Brief: Medicamen Biotech Announces Strategic Expansion Into Regulated Markets
Brief: Medicamen Biotech Enters Agreement With South African Conglomerate
Brief: Medicamen Biotech Issues Shares Worth Upto 689 Million Rupees
India's Medicamen Biotech jumps on 10-year contract
Brief: Medicamen Biotech Enters Manufacturing & Supply Agreement With US, Europe Pharma Distributor
Brief: Medicamen Biotech Says US FDA Approved Sterile Injectable Oncology Formulation Facility At Haridwar
India's Medicamen Biotech rises on facility getting EU GMP certification
Brief: Medicamen Biotech Gets EU GMP Certification For Bhiwadi Formulation Facility
Brief: Medicamen Biotech Says Ethiopian FDA Conducted Audit Of Oncology Plant, Haridwar
India's Medicamen Biotech hits 3-mth high on US FDA cancer drug application
Brief: Medicamen Biotech Has Filed First ANDA In ECTD Format For Bortezomib For Injection 3.5 Mg/Vial With USFDA
Brief: Medicamen Biotech Approves Final Dividend 1 Rupee Per Share
Brief: Medicamen Biotech Ltd Dec-Quarter Consol Net Profit Falls
Brief: Medicamen Biotech Forays Into Domestic Pharma Business Via Unit